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seroconversion pands in comparison with HIV DUO fourth generation
assay.
Results: HIV DUO showed sensitivity of 100% and specificity of 99.6%
among 1100 sera obtained from hospitalized patients or blood donnors. Tests
on sera obtained from commercial available as well as "in house" serocon-
version panels showed that HIV DUO is able to reveal an infected state, in II
out of 14 cases, earlier than conventional assay.
Conclusions: The new HIV DUO bioMerieux assay improves olds tests
performances in terms of sensitivity maintaining specificity at very high
levels.
IMoP39IAutomated TMA amplification and VIDAS detection
of a quantitative HIV-1 RNA test
]. 1. Bur~I,J.M. McCartyl, B. Weinbaum2, P.]. Levasseurl , P. M.
MacLean
IbioMerieux, Inc., Rockland, MA; 2Cen-Probe, Inc., San Diego, CA, United
States
Objectives: To develop a quantitative HIV-l viral load assay with AMP-
station for TMA (transcription-mediated amplification) and VIDAS for
detection.
Methods: Plasma samples containing HIV-I were added to a lysis reagent
containing IC (internal control) RNA. HIV-I genomic RNA and IC RNA
were captured onto paramagnetic particles with identical probes. Calibrators
and controls were processed similarly in parallel. After washing, particles
were resuspended and added directly to TMA reagent in a VIDAS PROBE
strip. Strips were placed in the AMPsration where a unit-dose enzyme pellet
was dissolved to initiate TMA. After amplification at 42°C for 60 minutes,
the TMA reaction was terminated by thermal inactivation of enzyme
activities. Strips were transferred to the VIDAS instrument and TMA
products (amplicons) detected in a three-part assay format designed for
high and low viral loads, and detection of the IC. Quantitation, based on
fluorescence kinetics, was achieved by interpolation to two overlapping
master calibration curves adjusted for each batch by run-specific calibrator
results.
Results: IC signals for undetectable HIV-1 samples reproducibly averaged
80 RFU/min, indicating that the IC RNA consistently verifies proper
sample processing, amplification and detection, including reproducible
performance of the AMPsration and VIDAS instruments. Linearity was
observed from 50 to > 100,000 HIV-I RNA copies/mi. Preliminary intra-
assay precision experiments showed CVs less than 30% for HIV-I RNA
inputs as low as 100 copies/mi. As part of an ongoing study, a blind
comparison was made to a peR method for the quantitation of clinical
specimens. Results, with a small number of specimens, showed 100%
concordance with a mean difference of 0.205 log10 RNA copies/mi.
Conclusions: The VIOAS PROBE Quantitative HIV-l Test gave accurate
vital load determination and should be useful in the management of HIV-I
infections.
IMoP40IEvaluation of a commercial test for the detection of
HIV-1 antibodies in urine samples
1. Matasl,]. Almeda2,]. Casabona2, V. Gonzalezl , R. Muga3, M. Vall',
B. Sanz', F. Bolaos, V. Ausina'
IServei de Microbiologia; 2CEESCAT; JMedicina Imerna; Hospital Germans
TritU i Pujol de Badalona; 'Unitat de Malalties de Transmissio Sexual, CAP
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IMo02S1 Human herpesvirus-6 infection after liver
transplantation
I. Lautenschlager, K. Linnavuori, M. Lappalainen,]. Suni, K. Hockerstedt
Departments of Virology and Surgery, Helsinki University Central Hospital,
Helsinki, Finland
Human herpesviruHI (HHV-6) infection has recently been reported in liver
transplant patients. In addition to clinical symptoms, such as fever, HHV-6
Drassanes Barcelona; sUnitat drogotlependincies Hospital Bellvitge, Hospitalet
tie Llobregal, Barcelona, Spain
Objective: Evaluation of the test Seradyn® Sentinel HIV-I Urine EIA
(Seradyn Inc, Indianapolis IN) to detect HIV-I antibodies in urine samples.
Methods: Urine and serum samples were obtained from 151 patients
attended in a sexually transmitted disease clinic (STDC) and from 97 patients
from two drug dependency treatment centres (DDTC). HIV-l antibody
detection in serum was performed using the routine EIA test (Bioelisa HIV-l
+ 2, Biokit). Positive results were confirmed by Western-blot test (New
Lab Blot I, Sanofi). HIV-l antibody detection in urine, samples was
performed according, to the manufacturer's recommendations. Reactive
urine samples were confirmed by the adaptation of me Biotest H1V-l
Western-blot test.
Results: 248 patients were included, 55 (22%) having H1V-l antibodies
(46% ofthe DDTC's patients and 6.6% ofthe STDC's patients). Discordant
results were found in five cases: 2 urine samples from HIV-l, positive
patients were negative, and 3 urine samples with EIA positive result ftom
HIV-I negative patients. None of them were confirmed by urine western-
blot test. Sensitivity, specificity and positive and negative predictive values
(pPV and NPV) for both groups are the following:
Positive Neg.tive Sensitivity Specificity PPV NPV
HIV HIV
STDC 10 141 0.83 0.99 0.90 0.90
DDTC 45 52 1.00 0.% 0.95 1.00
Tot21 55 193 0.% 0.98 0.94 0.98
COndusions: Seradyn® Sentinel HIV-l Urine EIA has proven to be a
reliable tool for large screening programmes. Additionally, ease ofspecimen
collection and safety issue make this test particularly attractive for screening
programmes.
IMoP41 IGenotypic resistance to NRTls measured by UPA
HIV·1 RT
F. Garcia, M. Alvarez, N. M. Martinez, P. Morara, M. C. Hemal, F.
GarciaJr.,]. Hernandez, I. Lopez, G. Piedrola, M. C. Maroro
Microbiology and 1. Diseases Units, Universitary Hospital, Granada, Spain
Objective: to evaluate the incidence of genotypic resistance to NRTis at
HIV-l infected patients from Southern Spain and with HAART.
Patients and Methods: 42 patients on HAART (16 females, 26 males; mean
age: 34.46 ± 8.41; risk factors: 20 IYDU, 17 heterosexual, 4 homosexual
males and 1 transfusion) and with virological failure have been studied.
Previous treatments and genotypic resisrance (INNO LIPA HIV-l RT)
were studied.
Results: 32 patients showed resistance to AZT (76.2%), 8 to 3TC (19%), 2
(4.7%) to DOl and 2 (4.7%) to DOC. Related to the number of patients/
year on treatment with each NRTI, the incidence of the resistance was: 25.8
(17.59-26.85) for AZT, 19.5 (8.4-38.3) for 3TC, 6.4 (0.7-23.2) for DOC
and 4.4 (0.5-16) for 001. No influence of sex or risk factor on AZT
genotype resistance was observed. After 6 months of resistance testing and
therapy modification viral load was reduced as follows: 3 Logs, 11.5%; 2
Logs, 11.5%; and 1 Log, 23%.
Conclusions: the highest incidence ofgenotype resistance to Nitres at HIV-l
infected patients from Southern Spain was for AZT, followed by 3TC. For
001 and DDC a lower incidence of genotype resistance has been observed.
may infect the transplant and cause graft dysfunction. In this study, the
frequency and clinical findings of HHV-6 infection were investigated in
liver transplant patients.
Methods: Consecutive 100 adult liver allograft recipients transplanted
during 1996-99 were included in the study. The patients were frequently
monitored for HHV-6 during 6 months after transplantation. The diagnosis
ofHHV-6 infection was based on the demonstration ofviral antigens in the
peripheral blood mononuclear cells, and in liver biopsies, by immunoper-
oxidase staining using monoclonal antibodies against HHV-6 antigens, and
on serology. The patients were also monitored for cytomegalovirus (CMV).
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CMV infections were diagnosed by pp65 antigenemia test and viral cultures
and treated with ganciclovir.
Results: During the first six months (6-172 days) after transplantation, 56
out of 100 (56%) adult liver transplant patients developed HHV-6 anti-
genemia. According to serology, all infections were reactivations. HHV-6
antigenemia lasted from one to several weeks, but clinical symptoms were
seldom seen, abdominal pain or fever in 7/56 cases. Graft dysfunction was
associated with HHV-6 in 40/56 patients. HHV-6 antigens were also
detected in the liver biopsies of 18/40 patients with graft dysfunction and
HHV-6 antigenemia. CMV infection was diagnosed closely associated with
HHV-6 in 14/56 patients and treated with ganciclovir. HHV-6 also
responded to ganciclovir treatment, but the effect was less pronounced
than that on CMV and HHV-6 antigenemia lasted longer than CMV
antigenemia.
Conclusions: HHV-6 reactivations are common in adult liver transplant
patients. Clinical symptoms are usually mild, ifany, but graft dysfunction is
often associated with HHV-6 antigenemia together with HHV-6 antigens in
the liver.
IMo029I Natural history of chronic hepatitis C in children
G. V. Zuccotti, E. D'Auria, M. Torcoletti, L. Tegaldo, E. Riva
Department of Paediatrics, San Paolo Hospital, Milan, Italy
Objective: To evaluate the natural course of vertically HCV infected
children
Methods: We prospectively observed from birth eleven vertically HCV
infected children for a mean period of79 months (range, 42-144 months).
Seven of them were born to HCV- and HIV-coinfeeted mothers and 4 to
HCV-infected mothers. HCV RNA was detected by R T-PCR amplifica-
tion with nested primers from 5' UTR.
Results: HCV RNA was first detected by 3 months ofage in all patients and
persisted in 10/11 throughout the follow up. Elevation of serum alanine
aminotransferase (ALT) levels was first detected at age 3 months and ALT
fiuctations persisted throughout follow up in all but two children. In these
latter ALT values returned to normal after 4 years of age and persisted
normal up to II and 12 years respectively.
Spontaneous remission, defined as a biochemical remission lasting more
than 1 year in association with the disappearance of serum HCV RNA,
occurred in I (9%). Physical examination findings and growth were
constandy normal. During the follow-up all patients were asymptomatic.
Chronic lobular hepatitis was demonstrated in 6 patients at liver biopsy
performed between I and 7 years of age.
Conclusions: Chronic hepatitis C >cern. to be a mild disease in childhood,
therefore we may hypothesize that therapy is not necessary at least in the first
twelve years of age.
IMo030IMortality and predidOrs of fibrosis in hepatitis C in
Trent region
A. Mohsen, R. Finch, M. Wiselka, S. Green, M. W. McKendrick
Trent HCV Study Group; , United Kingdom
Objectives: To investigate predictors ofliver fibrosis in a cohort of HCV
positive patients and the impact of liver disease on mortality.
Methods: Patients positive for HCV antibody were referred to one of 6
referral centres within a UK region of 5.12 million. Patients were investi-
gated and treated according to an agreed protocol. Patients co-infected with
HIV, on haemodyalysis and haemopheliacs were excluded from this study.
Liver biopsies were scored by single observer.
Results: Between 1991 and December 1998, 1139 patients have been
recruited to this cohort (775 male/3M female). 397 initial liver biopsies
have been examined and scored (Knodell) by a single observer. There was
correlation (R = 0.95) between fibrosis grade III/IV and alcohol intake.
Multivariate analysis demonstrated an association with age> 35 years (p =
0.0007) and previous hep B infection [(hepBcAb +vel p = O.OO4J regardless
of the persistence ofHbsAg, but no independent association with genotype,
gender, estemated duration of infection and route of infection. 9 patients
developed hepatocellular carcinoma. 66 deaths were recorded, 31 due to
liver or related liver disease, 12 lifestyle (suicide/murder), 15 unrelated
medical, 8 no data. Using age and sex specific death rates the relative increase
mortality for males was 3.9 (CI = 3.3-4.4) and for females 2.9 (CI = 1.1-
3.9)
Conclusion: Evidence of previous hepatitis B-infection, higher alcohol
consumption and older age was associated with a worse fibrosis score. All
cause mortality was high for a young cohort with almost half having a
hepatic cause.
IMo031 IRSV infection among hospitalized children In greece
G. Antonakil, K. Kallergil, M. Tsolia2, A. A1atzatzogloul , TH. Zagouris1,
M. Foustoukou·
I SNology Department; 2Department ofPediatrics, Children's Hospital "P & A
Kyriakou", Athens, Greece
Objectives: To investigate RSV infection among hospitalized children in
Greece during 1997-1999.
Methods: A total of405 nasal washes or nasopharyngeal aspirates, collected
from hospitalized children (aged < 2 years) with acute lower respiratory
tract disease during two winter seasons 1997/98 and 1998/99, were analyzed
for RSVantigen by DFA. RSV subgroup classification was performed with
specific monoclonal antibodies against RSV group A by IFA. Blood samples
were also obtained for the measurement of RSV specific IgG and IgM
antibodies by ELISA.
Results: During this study period 194 out of 405 specimens were RSV
positives (47.9%). 68% from the RSV positives for the winter season 1997/
98 and 58% for the next season 1998/99 were identified as group A. Anti
RSV seropositivity showed no significant difference between RSVinfected
and non infected children. 50% of the RSV infected children reported
history of atopy in their family compared to 33% in non infected children.
Abnormal chest radiograph characterized significandy more frequendy
infections with RSV group A (90%), than group B (60%).
Condusions: • RSV group A dominated during the study period.
• Serology was of limited value in the diagnosis of acute RSV infection.
• Family history of atopy predisposed to RSV infection.
• Group A RSV infections were more severe.
IMo032ILung fundion after severe varicella - A prospective
study
M. W. McKendrick, A. H. Mohsen
Department of Infection and Tropical Medkine, Sheffield, United Kingdom
Objectives: To study lung function in hospitalised patients with chickenpox
and to observe factors associated with severe disease.
Methods: Patients hospitalised with chicken pox were included ifthey were
immunocompetent and had no history of previous lung disease. Clinical,
laboratory and epidemiological data were collected. Spirometry and diffu-
sion studies were performed at discharge, 2 months and every 3 month until
normalization or I-year had elapsed. Results were considered abnormal if
they were outside 80% of predicted values.
Results: 38 patients (14female/24 male) were recruited. Mean age was 28.8
years. 18 had radiological pneumonia and 19 had normal CXR. FVC was
abnormal initially in 8 patients but normalized in all but 2. FEVI was
marginally abnormal in 3 patients at one year. TLCO was abnormal in 31/37
on discharge (average reduction of 42.4%); 14 patients reached normal
values within 12 months. In 10 patientsthe average reduction ofTLCO at 12
months was 36-39% (SO 8%) of predicted values. These levels had
plateaued by 5 months. Factors predicted the development of pneumonia
were number of spots (p = 0.029), smoking (p = 0.(04), history with
contact with own child (p = 0.03), and chest symptoms at presentation (p =
0.(04). Smokers had an average number of spots in a defined area on the
chest of 136 compared with non-smokers 71 (p = 0.005)
Conclusion: chickenpox may result in a defect oftransfer factor for at least a
year after acute illness and may be associated with a temporary restrictive
lung defect. Radiological pneumonia was more common in patients who
smoked, had more skin spots and had a history of close contact with
chickenpox. Smokers were noted to have more skin lesions than non-
smokers in this study.
IMo033Isequelae of TICk-Borne Encephalitis (TBE) - OWn
observations
S. Pancewicz, T. Hermanowska-Szpakowicz,j. Zajkowska, S.
Grygorczuk, M. Kondrusik, R. Swierzbiitska
Medical Academy ofBialystok, Poland
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objectives: The purpose of this work was evaluation of the course of the
disease; and its sequelae.
Methods: 364 patients were subjected to examination. They were hospita-
lized between 1993-1999 in Department of Neuroinfections and Parasitic
Diseases with diagnosis ofTBE. The diagnosis was based on epidemiologic
data clinical observations as well as examination of cerebrospinal 8uid and
serologic detection of antibodies against TBE virus in serum and CSF-elass
IgM and IgG (ELISA method with kits IMMUNOENZYM FSME IgM
and IgG by IMMUNO AG (Austria)
Results: In following ycars we hospitalized: 1993- 80 (21.98%). 1994- 70
(19.23%).1995- 49 (13.46%).1996- 54 (14.83%). 1997- 57 (15.66%). 1998-
44 (12.08%).1999-10 (2.75%) patients. The following clinical forms of the
disease were observed: Meningitis-145 (39.83%). Meningoencephalitis-l72
(47.25%). Encephalitis-23 (6.32%) and Meningoencephalomyelitis-16
(4.39%) patients. Among 28 (7.69%) patients coinfection with Borrelia
brugdorferi was stated. The sequelae after TBE were observed in 47
(12.91 %) patients: brachial plexy paresis-14 (29.79%), radiculitis-3
(6.38%), paresis of cranial nerves mostly n. VII u 8 (17.02%). hypoacusis-
3 (6.38%). synclroma cerebellaris-3 (6.38%), paraparesis-2 (4.25%), tetra-
paresis-l (2.13%) and hepatitis 7 (14.89%). pneumonia-3 (6.38%). endo-
carditis-2 (4.25%) and diabetes incipidus u 1 (2.13%). In analysed group of
patients there were no deaths.Conclusions Tick-Borne Encephalitis is viral
disease ofcentral nervous system often with severe course and sequelae wich
are connected not only with CNS but also with peripheral nervous system as
well as other systems and organs
IMo0341lWO cases of human rabies developed in spite of
postexposure prophylaxis
S. Ozer. O. Ak. N. Benzonana.1. Kuzu
KEAH Injectious Diseases and Clinical Microbiology Dept. Istanbul, Turkey
Two boys aged 11 and 13 years old were bitten by the same dog. In the first
case the lesion was in the frontoparietal region extending to the upper eyelid.
in the latter the lesion was below the lips. Both cases were subjected to
wound care without sutures; equine antirabies serum and human diploid cell
vaccine were administered followed by tetanus vaccination. Antibiotic
therapy was instituted and the patients were hospitalized so that vaccination
schedule could regularly be followed and the wounds treated. The semi-
owned unvaccinated dog died in the fifth day and was histopathologically
shown to be rabid. On the thirteenth day the first case ran temperature. He
presented signs ofencephalitis and died on the seventeenth day. The autopsy
led to the diagnosis ofrabies encephalitis. The other child remained healthy.
A ten year old girl was bitten by a stray dog in the frontoparietal region
and near the upper eyelid. She was subjected to wound care and one ofher
wounds was sutured. equine rabies immune globulin and human diploid cell
vaccine followed by tetanus vaccination and antibiotherapy was started. The
dog was killed and shown to be rabid. The vaccine schedule was followed
properly. On the 16th day she had aerophobia and hydrophobia and was
brought to our hospital. She died two days later and autopsy revealed rabies
encephalitis.
Rabies can still be a fatal disease despite proper postexposure prophylaxis
in cases which although very rarely the virus may have entered directly in to
the nervous system.
IMo03S1 Rotavirus encephalopathy: Pathogenetic
mechanisms reviewed
Paul N. Goldwater
Microbiology & Infectious Diseases Department, The Women's & Children's
Hospital, North Adelaide, Australia
Objectives: To review pathogenetic mechanisms of rotavirus encephalo-
pathy.
Methods: Literature review and findings obtained from two clinical cases.
Review: 2% of cases of rotavirus gastroenteritis exhibit neurological
symptoms and signs. Two recent cases ofrotavirus gastroenteritis associated
with neurological involvement - one with encephalitis (defined by abnormal
neurological signs, cerebrospinal 8uid (CSF) pleocytosis & detection of
rotavirus genomic RNA in the CSF [the rotavirus was serotype GIl) and
one with a non-in8ammatory encephalopathy (defined by abnormal neu-
rological signs. an entirely normal CSF & detection of rotavirus genomic
nucleic acid in the CSF [this totavirus was serotype G3)) serve as a basis to
explore potential pathogenetic mechanisms. Possibilities include direct vital
replication within neurones or indirect effects of the newly described
rotavirus "enterotoxin". The pathogenesis of rotavirus-associated encepha-
litis or encephalopathy has remained enigmatic, however. it is known that
rotavirus can indeed infect neuronal cells in vitro and in vivo and thus there is a
basis for a direct pathogenetic mechanism. The notion that gut-derived
toxins entering the blood stream from the rotavirus-damaged intestinal
mucosa is another possibility, but less plausible, as detection of bacterial
toxaemia in rotavirus diarrhoea cases has not. to my knowledge, been
reported. The novel claim that rotavirus non-structural protein 4 (NSP4) is
the first viral enterotoxin deserves further consideration in this regard, as it
seems that NSP4 is a strong secretory agonist mobilising intracellular
calcium. It is plausible that NSP4 or a peptide derivative could act either
directly through neuronal vital infection (supported by finding rotaviral
RNA in CSF) or indirectly through blood-borne delivery from the gut to
the brain.
Conclusion: In both clinical cases, rotavirus RNA was detected by RT-
PCR in CSF specimens. and suppom a direct effect ofThe virus on neuronal
cells.
P:2/1 - Hepatitis
IMoP42! Hemodynamics in patients with chronic viral
hepatitis Band C
I. V. Maev. N. D. Yushchouk. P. G. Filippov
Moscow State University ofMedicine and Dentistry, Moscow, Russian
Federation
Objectives: To investigate the peculiarities of the central hemodynamics,
portal hepatic circulation and microhemocirculation in patients with acute
and chronic viral hepatitis B and C.
Methods: We have observed 110 patients suffering from chronic viral
hepatitis (the average age was 39 + 1.7). among them 61.7% - men. and
38.3% women). Chronic hepatitis B (HCY) - in 30 patients, and 34 patients
had B + C (HB + CV). The hemodynamics condition was evaluated with
the help ofultrasonic scanning ofthe heart and vessels. Doppler bloodstream
investigation and radioisotope methods.
Results: The evaluation of the left cardiac divisions, undertaken on the
7th-10th day after the onset or exacerbation of the disease, revealed the
thickening ofthe left ventricular (LY) walls and its weight increase. In 31.1 %
ofpatients with HBS and 49% ofpatients with HCV the values oftheir final
diastolic (FDV) and final systolic (FSV) volumes of the left ventricle were
higher then a normal variation peak. A decrease in the output fraction (OF),
in the degree of shortening of the anterior-posterior LV dimensions (~S)
and in the speed of myocardial fiber circulatory shoncning (Vet) were
recorded. There was also recorded an increase in the cardiac index (Cl), best
expressed in ChHBC. A meaningful correlation was revealed between CI
and the bloodflow diameter and speed in the portal and splenic veins. In the
course of the microhemocirculation analysis of the patients with HCV and
HB + CV the changes were most well-expressed (53.3 and 76.5%). They
were a generalised arteriole spasm. changes in the arteriole shape, capillary
widening, and 52.9% of these patients had a decrease in lumen and
obturation of the capillary network. Arteriolo-venular shunts were
encounted in 21.7-41.2%.
Conclusion: The obtained results testify to severe hemodynamic abnorm-
alities in patients with acute and chronic viral hepatitis B and C.
IMoP43IHigh prevalence of HCV in thalassemic patients in
Shahr-E-Kord (Southwestern of Iran)
M. Avijegan, M. Bassirat Nia. S. M. K. Hosseini Asi. F. Heidarian
Peditric Ward of Shahr-E-Kord Uni. ofMed. Sciences, Shahr-E-Kord, Iran
Setting: HCV is the most common cause of post-transfusional hepatitis.
The thalassemic patients with multiple transfusion are at high risk of HCV
involvement and also mortality due to chronic HCV infection. Although
they are treatable with bone marrow transplantation.
Aim: TO determine the high prevalence HCV in thalassemic patients. and
to indicate that they are a rather major source of HCV.
Method and Material Anti-HCV and alanine transferase tests (ALT) carried
our on 113 thalassemic patients. To exclude false positive results in Anti-
HCV. all of the HCV positive sera controlled with Recombinant Immuno
Blot Assay (RIBA).
Results: HCV prevalence was 23%. The M:F ratio was 1/3:1. Most of the
posiTive cases aged more than 10 years old. whereas the negative cases aged
